The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Cardiac Surgery
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Objective: The aim of this study was to determine the effect of dexmedetomidine in reducing
postoperative cognitive dysfunction (POCD) in cardiac surgical patients which use
cardiopulmonary bypass machine (CPB).
Materials and Methods: This study was double-blinded, randomized controlled trial. Patients
scheduled for elective CPB facilitated cardiac surgery were randomly assigned in two groups,
dexmedetomidine group (DEX) or control group. The cognitive tests (MoCA test and Short bless
test) were done before the operation, 48 hours, and 7 days postoperatively. POCD was defined
as a decline of 1SD of baseline score in any test. Arterial blood sample were analyzed for
IL-6, IL-10, TNF-alpha and hs-CRP before induction (T0), after separation from CPB (T1),
arrival at ICU (T2) and 24-hour after surgery (T3). Primary outcome was the incidence of POCD
and the secondary outcomes were inflammatory response, other postoperative complications, ICU
and hospital stay.